Skip to main navigation Skip to search Skip to main content

Nuwellis’ Strategic Partner, SeaStar Medical, Receives FDA Approvable Letter for Its Pediatric Selective Cytopheretic Device

  • Kevin Chung

Press/Media

Period31 Oct 2023

Media coverage

7

Media coverage